ArthroCare Corporation Market Share Analysis

ArthroCare Corporation Market Share Analysis

Summary

Our new report, “ArthroCare Corporation Market Share Analysis” provides in-depth information on ArthroCare Corporation’s market position in the different medical equipment markets it operates in. The report provides ArthroCare Corporation market share information in two key market categories – Arthroscopy and Spinal Surgery. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets ArthroCare Corporation operates in – Orthopedic Devices.
- ArthroCare Corporation’s company shares (in Revenues) information for all the key countries the company has presence in – Japan, India, China, Australia, Spain, United Kingdom, Germany, Italy, France, Canada, United States and Brazil.
- ArthroCare Corporation’s company shares (in Revenues) information for all the key market categories the company has presence in – Arthroscopy and Spinal Surgery.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, ArthroCare Corporation operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to ArthroCare Corporation’s market positions. SHOW LESS READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Orthopedic Devices
3.1.1 Arthroscopy
3.1.2 Spinal Surgery
4 Company Snapshot
4.1 Key Key Facts
4.2 Company Overview
4.3 Financial Performance
4.4 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Other
5.2.1 Overview
5.2.2 Financials
5.2.3 Market View
5.3 Sports Medicine
5.3.1 Overview
5.3.2 Financials
5.3.3 Market View
5.4 Major Products and Services
5.4.1 Overview
6 History
7 Business Strategy
7.1 Mission Statement
8 SWOT Analysis
8.1 Overview
8.2 ArthroCare Corporation Strengths
8.2.1 Focus on Research and Development Activities
8.2.2 Proprietary Coblation Technology
8.2.3 Diversified Operations
8.3 ArthroCare Corporation Weaknesses
8.3.1 Dependence on the US Market
8.3.2 Governmental Investigations
8.3.3 Decline in Current Asset Turnover
8.4 ArthroCare Corporation Opportunities
8.4.1 Product Approvals
8.4.2 Growth in Arthroscopy Market
8.4.3 Growing Spinal Surgery Procedures
8.4.4 Market Growth in Emerging Economies
8.5 ArthroCare Corporation Threats
8.5.1 Stringent Government Regulations
8.5.2 Competitive Landscape
8.5.3 Dependent on Few Suppliers
8.5.4 Growing Consolidation in the Industry
9 Competitors
10 Competitive Landscape
10.1 Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011
10.2 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Region, Market Share (2011)
10.3 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Country, Market Share (2011)
10.4 Orthopedic Devices (Arthroscopy), Global, Market Share (%), 2011
10.5 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Region, Market Share (2011)
10.6 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Country, Market Share (2011)
11 Share Holding Structure
12 Key Employees
13 Key Employee Biographies
14 Company Statement
15 Locations And Subsidiaries
15.1 Head Office
15.2 Other Locations & Subsidiaries
16 Financial Deals Landscape
16.1 ArthroCare Corporation, Deals Volume Summary, 2007 to YTD 2013
17 ArthroCare Corporation, Deals Summary By Region, 2007 to YTD 2013
18 ArthroCare Corporation Detailed Deal Summary
18.1 Partnerships
18.1.1 Wright Medical Enters Into Distribution Agreement With ArthroCare
18.2 Equity Offering
18.2.1 ArthroCare Completes Private Placement Of $75 Million
18.3 Asset Transactions
18.3.1 NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare
18.4 Acquisition
18.4.1 ArthroCare Acquires OrtoConcept
18.4.2 ArthroCare Acquires DiscoCare
19 Recent Developments
19.1 Financial Announcements
19.1.1 Oct 31, 2012: ArthroCare Reports Revenue Of $86.9m In Q3 2012
19.1.2 Aug 01, 2012: ArthroCare Reports Revenue Of $91.7m In Q2 2012
19.1.3 May 02, 2012: ArthroCare Reports Revenue Of $92.9m In Q1 2012
19.1.4 Feb 16, 2012: ArthroCare Reports Revenue Of $354.9m In 2011
19.1.5 Nov 02, 2011: ArthroCare Reports Revenues Of $83.3m In Q3 2011
19.1.6 Aug 03, 2011: ArthroCare Reports Total Revenue Of $91.3m In Q2 2011
19.1.7 May 02, 2011: ArthroCare Reports Total Revenue Of $87.9m In Q1 2011
19.1.8 Feb 14, 2011: ArthroCare Reports Total Revenues Of $355.38m In 2010
19.1.9 Nov 01, 2010: ArthroCare Reports Net Income Of $9.26 Million For Q3 2010
19.1.10 Aug 03, 2010: ArthroCare Reports Net Income Of $7.27 Million In Q2 2010
19.1.11 May 05, 2010: ArthroCare Reports Net Income Of $8.8 Million In Q1 2010
19.1.12 Mar 15, 2010: ArthroCare Reports Total Revenues Of $331.6 Million In 2009
19.1.13 Nov 24, 2009: ArthroCare Reports Total Revenues Of $79.5 Million In Q3 2009
19.1.14 Nov 19, 2009: ArthroCare Reports Revenue Of $80.8 Million For Q2 2009
19.1.15 Apr 21, 2008: ArthroCare Declares Q1 2008 Results
19.1.16 Feb 26, 2008: ArthroCare Board Extends Share Repurchase Plan
19.1.17 Feb 19, 2008: ArthroCare Declares Q4 2007 Results
19.1.18 Oct 22, 2007: ArthroCare Declares Q3 2007 Results
19.1.19 Jul 26, 2007: ArthroCare Declares Q2 2007 Results
19.1.20 Apr 26, 2007: ArthroCare Q1 Revenue Up 18% To $73.7 Million
19.1.21 Feb 15, 2007: ArthroCare Q4 Revenue Up 18% To $69.8 Million
19.1.22 Jan 09, 2007: ArthroCare Sees Q4 2006 Revenues At $69.7 Million
19.1.23 Oct 26, 2006: ArthroCare Q3 2006 Total Revenue Up 21% To $64.7 Million
19.1.24 Aug 03, 2006: ArthroCare Q2 2006 Revenue Up 28% To $51.7 Million
19.2 Corporate Communications
19.2.1 Jan 19, 2010: ArthroCare Shares To Begin Trading Oon NASDAQ Global Market
19.2.2 Jan 04, 2010: ArthroCare Appoints Scott Schaffner As Senior Vice President And General Manager Of Sports Medicine
19.2.3 Oct 26, 2009: ArthroCare Appoints David Fitzgerald As President, CEO
19.2.4 Jul 01, 2009: ArthroCare Appoints Andrew Miclot As SVP, General Manager Of ENT Business
19.2.5 Apr 02, 2009: ArthroCare Names Todd Newton As Senior Vice President, CFO
19.2.6 Feb 18, 2009: ArthroCare Announces Management Changes
19.2.7 Jan 15, 2009: ArthroCare Gets Nasdaq Delisting Notice
19.2.8 Dec 19, 2008: ArthroCare Announces Management Resignations
19.2.9 Dec 19, 2008: ArthroCare Announces Senior Management Promotions
19.2.10 Dec 01, 2008: ArthroCare Announces Decision From NASDAQ Granting Its Request For Continued Listing
19.2.11 Nov 18, 2008: ArthroCare Receives Deficiency Notice From Nasdaq
19.2.12 Dec 14, 2006: ArthroCare Expands Board
19.3 Legal and Regulatory
19.3.1 Aug 22, 2012: Two Former Senior Executives of ArthroCare Arrested In $400m Securities Fraud Scheme
19.3.2 Nov 28, 2011: ArthroCare Announces Agreement In Principle To Settle Securities Class Action
19.3.3 Feb 09, 2011: ArthroCare Announces Settlement Of SEC Investigation
19.3.4 Mar 04, 2010: Arthrocare Enters Settlement Agreement With Nationwide In Reimbursement Dispute
19.3.5 Dec 08, 2009: ArthroCare To Pay About $1 Million To Settle With Several Insurers Over SpineWand Reimbursement Claims
19.3.6 Feb 18, 2009: ArthroCare Announces Investigations By SEC And US Attorney Offices
19.3.7 Jul 24, 2008: ArthroCare Says SEC Starts Informal Inquiry Into Accounting Practices After Restatement
19.3.8 Apr 07, 2008: Sarraf Files Lawsuit Against ArthroCare
19.4 Product News
19.4.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device
19.4.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System
19.4.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant
19.4.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device
19.4.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant
19.4.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device
19.4.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix
19.4.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant
19.4.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device
19.4.10 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery
19.4.11 Jun 23, 2008: Two Studies At World Oncology Conference Support ArthroCare SpineWand
19.4.12 Jun 19, 2008: ArthroCare Corporation (ARTC) Launches DoublePlay New Osteoconductive Suture Anchor
19.4.13 Jun 19, 2008: ArthroCare Corporation (ARTC) Sets New Standard In Modern Arthroscopy Launches New Quantum Pump Arthroscopy System
19.4.14 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows
19.4.15 Apr 10, 2008: ArthroCare Announces Parallax Contour, A New Device For Mechanical Void Creation
19.4.16 Apr 03, 2008: ArthroCare Unveils New Direction In Treatment Of Metastatic Lesions
19.4.17 Oct 30, 2007: ArthroCare Launches Opus TwinLock Knotless Fixation System
19.4.18 Oct 23, 2007: ArthroCare Releases New SpineWand For Less Invasive Spinal Surgeries
19.4.19 May 22, 2007: Two Studies Indicate Coblation Safely Treats Symptomatic Chondral Defects in the Knee
19.4.20 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine
19.4.21 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System
19.4.22 Apr 27, 2006: Study Results Show Coblation Technology Preserves Same Amount of Healthy Cells as Mechanical Shaver in Treatment of Meniscus
19.4.23 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures
19.4.24 Aug 03, 2005: ArthroCare's TOPAZ Named Among Podiatry Today's Annual Top Ten Innovations List.
19.4.25 Nov 03, 2004: Live Webcast On Minimally Invasive Tendon And Fascia Treatments To Feature ArthroCare's TOPAZ Microdebrider
19.4.26 Apr 28, 2004: ArthroCare introduced two new SpineWands
19.4.27 Oct 15, 2003: Bilok(R) for ACL Fixation Now Available in United States
19.4.28 Apr 01, 2000: Arthrocare's Coblation System To Be Used For Brain Surgery
19.5 Product Approvals
19.5.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device
19.5.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System
19.5.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant
19.5.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device
19.5.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant
19.5.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device
19.5.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix
19.5.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant
19.5.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device
19.5.10 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine
19.5.11 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System
19.5.12 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures
19.6 Clinical Trials
19.6.1 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery
19.6.2 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows
20 Appendix
20.1 Research Methodology
20.2 Secondary Research
20.3 Primary Research
20.4 Models
20.5 Forecasts
20.6 Expert Panels
20.7 Consulting
20.8 Currency Conversion
20.9 Contact Us
20.10 Disclaimer

1.1 List of Tables
Table 1: ArthroCare Corporation, Key Facts
Table 2: ArthroCare Corporation, SWOT Analysis, 2011
Table 3: Orthopedic Devices (Spinal Surgery), Global, Company Share by Revenue ($m), 2011
Table 4: Orthopedic Devices, Market (Spinal Surgery), by Region, Revenue ($m) and Market Share (%), 2011
Table 5: ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Country, Revenue ($m) and Market Share (%), 2011
Table 6: Orthopedic Devices (Arthroscopy), Global, Company Share by Revenue ($m), 2011
Table 7: ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Region, Revenue ($m) and Market Share (%), 2011
Table 8: ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Country, Revenue ($m) and Market Share (%), 2011
Table 9: ArthroCare Corporation, Share Holding Structure
Table 10: ArthroCare Corporation, Key Employees
Table 11: ArthroCare Corporation, Other Locations
Table 12: ArthroCare Corporation, Subsidiaries
Table 13: ArthroCare Corporation, Deals Volume Summary, 2007 to YTD 2013
Table 14: ArthroCare Corporation, Deals Summary By Region, 2007 to YTD 2013
Table 15: ArthroCare Corporation, Deals Summary, 2007 to YTD 2013
Table 16: Wright Medical Enters Into Distribution Agreement With ArthroCare
Table 17: ArthroCare Completes Private Placement Of $75 Million
Table 18: NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare
Table 19: ArthroCare Acquires OrtoConcept
Table 20: ArthroCare Acquires DiscoCare
Table 21: USD to Local Currency, Average Exchange Rate, 2011

1.2 List of Figures
Figure 1: Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011
Figure 2: ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Country, Market Share (%), 2011
Figure 3: Orthopedic Devices (Arthroscopy), Global, Market Share (%), 2011
Figure 4: ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Region, Market Share (%), 2011
Figure 5: ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Country, Market Share (%), 2011
Figure 6: ArthroCare Corporation, Deals Volume Summary, 2007 to YTD 2013
Figure 7: ArthroCare Corporation, Deals Summary By Region, 2007 to YTD 2013

Medtronic, Inc.
Olympus Corporation
Smith & Nephew Plc
Stryker Corporation
Johnson & Johnson
Cardinal Health, Inc.
Arthrex, Inc.